Document is current

Any future updates will be listed below

Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia

Crossref DOI link: https://doi.org/10.1038/s41375-025-02833-x

Published Online: 2025-12-09

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark